Functional differences between integrin α4 and integrins α5/αv in modulating the motility of human oral squamous carcinoma cells in response to the V region and heparin-binding domain of fibronectin

Experimental Cell Research

Volumn 295, Issue 1, 2004, Pages 48-58

  Zhang, Yan ^a   Lu, Hai ^a   Dazin, Paul ^b   Kapila, Yvonne ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Fibronectin; Integrin; Migration; Squamous cell carcinoma

Indexed keywords

ALPHA4 INTEGRIN; ALPHA5 INTEGRIN; ANTISENSE OLIGONUCLEOTIDE; CD51 ANTIGEN; COMPLEMENTARY DNA; FIBRONECTIN; PROTEIN ANTIBODY; PROTEIN SUBUNIT; RECOMBINANT PROTEIN;

ARTICLE; BINDING AFFINITY; BINDING SITE; CANCER CELL; CARCINOMA CELL; CELL MIGRATION; CELL MOTILITY; CELL STIMULATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SQUAMOUS CELL CARCINOMA;

EID: 1642543205     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2003.12.011     Document Type: Article

References (40)

1. Ramos D.M., Chen B.L., Boylen K., Stern M., Kramer R.H., Sheppard D., Nishimura S.L., Greenspan D., Zardi L., Pytela R. Stromal fibroblasts influence oral squamous cell-carcinoma cell interactions with tenascin-C. Int. J. Cancer. 72:1997;369-376.
2. Nagakawa O., Ogasawara M., Fujii H., Murakami K., Murata J., Fuse H., Saiki I. Effect of prostatic neuropeptides on invasion and migration of PC-3 prostate cancer cells. Cancer Lett. 133:1998;27-33.
3. Terranova V.P., Hujanen E.S., Martin G.R. Basement membrane and the invasive activity of metastatic tumor cells. J. Natl. Cancer Inst. 77:1986;311-316.
4. Liotta L.A. Cancer cell invasion and metastasis. Sci. Am. 266:1992;34-41.
5. Holzmann B., Gosslar U., Bittner M. Alpha 4 integrins and tumor metastasis. Curr. Top. Microbiol. Immunol. 231:1998;125-141.
6. Liotta L.A. Tumor invasion and metastases - Role of the extracellular matrix: Rhoads Memorial award lecture. Cancer Res. 46:1986;1-7.
7. Hynes R.O. Fibronectins. 1990;249-280 Springer-Verlag, Berlin.
8. Garcia-Gila M., Lopez-Martin E.M., Garcia-Pardo A. Adhesion to fibronectin via α4 integrin (CD49d) protects B cells from apoptosis induced by serum deprivation but not via IgM or Fas/Apo-1 receptors. Clin. Exp. Immunol. 127:2002;455-462.
9. Thomas G.J., Lewis M.P., Hart I.R., Marshall J.F., Speight P.M. αVβ6 Integrin promotes invasion of squamous carcinoma cells through upregulation of matrix metalloproteinase-9. Int. J. Cancer. 92:2001;641-650.
10. Clark E.A., Brugge J.S. Integrins and signal transduction pathways: the road taken. Science. 268:1995;233-239.
11. Felsenfeld D.P., Choquet D., Sheetz M.P. Ligand binding regulates the directed movement of β1 integrins on fibroblasts. Nature. 383:1996;438-440.
12. Saki I., Murata J., Makabe T., Matsumoto Y., Ohdate Y., Kawase Y., Taguchi Y., Shimojo T., Kimizuka F., Kato I. Inhibition of lung metastasis by synthetic and recombinant fragments of human fibronectin with functional domains. Jpn. J. Cancer Res. 81:1990;1003-1011.
13. Akiyama S.K., Aota S., Yamada K.M. Function and receptor specificity of a minimal 20 kilodalton cell adhesive fragment of fibronectin. Cell Adhes. Commun. 3:1995;13-25.
14. Wayner E.A., Garcia-Pardo A., Humphries M.J., McDonald J.A., Carter W.G. Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J. Cell Biol. 109:1989;1321-1330.
15. Mould A.P., Humphries M.J. Identification of a novel recognition sequence for the integrin α4β1 in the COOH-terminal heparin-binding domain of fibronectin. EMBO J. 10:1991;4089-4095.
16. Mould A.P., Komoriya A., Yamada K.M., Humphries M.J. The CS5 peptide is a second site in the IIICS region of fibronectin recognized by the integrin α4β1. Inhibition of α4β1 function by RGD peptide homologues. J. Biol. Chem. 266:1991;3579-3585.
17. Iida J., Shubitz A.P., Furcht L.T., Wayner E.A., McCarthy J.B. Coordinate role for cell surface chondroitin sulfate proteoglycan and α4β1 integrin in mediating melanoma cell adhesion to fibronectin. J. Cell Biol. 118:1992;431-444.
18. Vogel B.E., Tarone G., Giancotti F.G., Gailit J., Ruoslahti E. A novel fibronectin receptor with an unexpected subunit composition (αvβ1). J. Biol. Chem. 265:1995;5934-5937.
19. Ruoslahti E. Fibronectin and its α5β1 integrin receptor in malignancy. Invasion Metastasis. 14:1994-1995;87-97.
20. Thomas G.J., Jones J., Speight P.M. Integrins and oral cancer. Oral Oncol. 33:1997;381-388.
21. Kapila Y.L., Niu J., Johnson P.W. The high affinity heparin-binding domain and the V region of fibronectin mediate invasion of human oral squamous cell carcinoma cells in vitro. J. Biol. Chem. 272:1997;18932-18938.
22. Matsumoto K., Matsumoto K., Nakamura T., Kramer R.H. Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J. Biol. Chem. 269:1994;31807-31813.
23. Kapila Y.L., Wang S., Johnson P.W. Mutations in the heparin binding domain of fibronectin in cooperation with the V region induce decreases in pp125(FAK) levels plus proteoglycan-mediated apoptosis via caspases. J. Biol. Chem. 274:1999;30906-30913.
24. Bober-Barkalow F.J., Schwarzbauer J.E. Localization of the major heparin binding site in fibronectin. J. Biol. Chem. 266:1991;7812-7818.
25. Janiak M., Hashmi H.R., Janowska-Wieczorek A. Use of the Matrigel-based assay to measure the invasiveness of leukemic cells. Exp. Hematol. 22:1994;559-565.
26. Murata K., Hirano K., Villa-Moruzzi E., Hartshome D.J., Brautigan D.L. Differential localization of myosin and myosin phosphatase subunits in smooth muscle cells and migrating fibroblasts. Mol. Biol. Cell. 8:1997;663-673.
27. Townsend P.A., Villanova I., Uhlmann E. An antisense oligonucleotide targeting the αV integrin gene inhibits adhesion and induces apoptosis in breast cancer cells. Eur. J. Cancer. 36:2000;397-409.
28. Lallier T., Bronner-Fraser M. Inhibition of neural crest cell attachment by integrin antisense oligonucleotides. Science. 259:1993;692-695.
29. Akhtar S., Kole R., Juliano R.L. Stability of antisense DNAoligodeoxynucleotide analogs in cellular extracts and sera. Life Sci. 49:1991;1793-1801.
30. Beauvais A., Erickson C.A., Goins T., Craig S.E., Humphries M.J., Thiery J.P., Dufour S. Changes in the fibronectin-specific integrin expression pattern modify the migratory behavior of sarcoma S180 cells in vitro and in the embryonic environment. J. Cell Biol. 128:1995;699-713.
31. Kawahara E., Tokuda R., Nakanishi I. Migratory phenotypes of HSC-3 squamous carcinoma cell line induced by EGF and PMA: relevance to migration of loosening of adhesion and vinculin-associated focal contacts with prominent filopodia. Cell Biol. Int. 23:1999;163-174.
32. Kapila Y.L., Wang S., Dazin P., Tafolla E., Mass M.J. The heparin-binding domain and V region of fibronectin regulate apoptosis by suppression of p53 and c-myc in human primary cells. J. Biol. Chem. 277:2002;8482-8491.
33. Pytela R., Pierschbacher M.D., Ruoslahti E. A 125/115-kDa cell surface receptor specific for vitronectin interacts with the arginine-glycine-aspartic acid adhesion sequence derived from fibronectin. Proc. Natl. Acad. Sci. U. S. A. 82:1985;5766-5770.
34. Van Waes C., Surh D.M., Chen Z., Kirby M., Rhim J.S., Brager R., Sessions R.B., Poore J., Wolf G.T., Carey T.E. Increase in suprabasilar integrin adhesion molecule expression in human epidermal neoplasms accompanies increased proliferation occurring with immortalization and tumor progression. Cancer Res. 55:1995;5434-5444.
35. Breuss J.M., Gallo J., DeLisser H.M., Klimanskaya I.V., Folkesson H.G., Pittet J.F., Nishimura S.L., Aldape K., Landers D.V., Carpenter W. Expression of the β6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J. Cell Sci. 108:1995;2241-2251.
36. Huhtala P., Humphries M.J., McCarthy J.B., Tremble P.M., Werb Z., Damsky C.H. Cooperative signaling by α5β1 and α4β1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J. Cell Biol. 129:1995;867-879.
37. Ruoslahti E. Fibronectin and its integrin receptors in cancer. Adv. Cancer Res. 76:1999;1-20.
38. Porter J.C., Hogg N. Integrin cross talk: activation of lymphocyte function-associated antigen-1 on human t cells alters α4β1- and α5β1-mediated function. J. Cell Biol. 138:1997;1437-1447.
39. Retta S.F., Balzac F., Ferraris P., Belkin A.M., Fässler R., Humphries M.J., De Leo G., Silengo L., Tarone G. β1-Integrin cytoplasmic subdomains involved in dominant negative function. Mol. Biol. Cell. 9:1998;715-731.
40. Weiss L., Orr F.W., Honn K.V. Interactions of cancer cells with the microvasculature during metastasis. FASEB J. 2:1988;12-21.